Lv3
290 积分 2022-05-17 加入
Discovery and Characterization of Allosteric WNK Kinase Inhibitors
1天前
已完结
Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria
1个月前
已完结
Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
1个月前
已完结
Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance
1个月前
已完结
Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor
4个月前
已完结
Targeting TBK1 to overcome resistance to cancer immunotherapy
4个月前
已完结
High-Throughput Kinetic Characterization of Irreversible Covalent Inhibitors of KRASG12C by Intact Protein MS and Targeted MRM
7个月前
已完结
Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity
7个月前
已完结
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update
8个月前
已完结
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy
8个月前
已完结
皖公网安备34019202002308
